Form 4 holding
Secretary/CEO of subsidiary
TherapeuticsMD, Inc.
- Security class
- Common Stock
- Shares / value
- 3,582,373
- Estimated value
- $8,020,933
- Report date
- 10 May 2021
- Price
- $2.24
- Ownership
- Indirect
John C.k. Milligan IV - Secretary/CEO of subsidiary at TherapeuticsMD, Inc.
Issuer-level insider activity
- Role
- Secretary/CEO of subsidiary
- Issuer ticker
- TXMD on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by John C.k. Milligan IV since 29 Oct 2025
Reported holdings for John C.k. Milligan IV in TherapeuticsMD, Inc.
Form 4 holding
Secretary/CEO of subsidiary
TherapeuticsMD, Inc.
- Security class
- Common Stock
- Shares / value
- 1,752,703
- Estimated value
- $3,924,302
- Report date
- 11 May 2021
- Price
- $2.24
- Ownership
- Direct
Form 4 holding
Secretary/CEO of subsidiary
TherapeuticsMD, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 207,000
- Estimated value
- $753,087
- Report date
- 10 May 2021
- Price
- $3.64
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for John C.k. Milligan IV in TherapeuticsMD, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.